The nine-week self-paced course launches September 21st. Learn more an enroll HERE.
Category: Biomanufacturing@MIT-CBI
The world needs more vaccines faster. A tiny tube could make all the difference.
Professor Richard Braatz was interviewed for an article in National Geographic about efforts to develop a continuous manufacturing processes that could help boost global vaccine availability.
Enroll in MIT xPro Course through March 3rd!
Our Principles of Biomanufacturing: Using Biotechnology to Manufacture Medicines online course has just launched. This six-week self-paced course offers scientists, chemists, researchers, program managers, and other biological medicine specialists an opportunity to build an integrated understanding of their role in biomanufacturing. ENROLL NOW!
BioACCESS contributes to the IAVI Wellcome report on expanding global access to mAb-based products.
BioACCESS took part in consultations and reviewed the IAVI Welcome report, which sets out a roadmap to make lifesaving antibody treatments affordable and available, particularly to those living in low- and middle-income countries. BioACCESS will take part in a series of webinars, virtual meetings, and publications to engage key stakeholders in taking concrete actions to…
BioPharm International publishes CBI Article on the Impact of SARS-CoV-2 on Biomanufacturing Operations
CBI has published a summary of the key takeaways from “The Impact of SARS-CoV-2 on Biomanufacturing Operations”, the first webinar in our ‘Biotechnology in the Age of COVID-19” series co-hosted by CAACB and BioMAN. The summary presents a snapshot of information drawn from expert presentations and a pre-workshop survey of consortia members, covering topics such as…
BioACCESS Receives Funding to Contribute to IBM Watson’s Initiative: Marshalling AI in the Fight Against COVID-19
The MIT-IBM Watson AI Lab is funding 10 research projects aimed at addressing the health and economic consequences of the pandemic, including BioACCESS’ Overcoming manufacturing and supply hurdles to provide global access to a coronavirus vaccine. The project, led by CBI’s Anthony Sinskey and Stacy Springs, will build data-driven statistical models to evaluate tradeoffs in scaling the manufacture…
Nature Biotechnology publishes CAACB Article on Viral Contamination in Biologic Manufacture and Implications for Emerging Therapies
This report, made possible through the efforts of our consortium members, offers lessons learned to help prevent viruses from contaminating biopharmaceutical manufacturing processes. Read the complete publication HERE. Read the MIT News piece HERE. Story: Ann Trafton, MIT News Office| Image: Betsy Skrip, CBI
Biotechnology in the Age of COVID-19 Webinar Series Launched, 4/19/2020
In response to the COVID-19 pandemic, the Center for Biomedical Innovation has hosted a series of collaborative webinars focused on how the biomanufacturing industry is coping with COVID-19. These informal meetings will be a place where industry experts will share their organization’s response to the unique challenges now facing biomanufacturing operations. These meetings are open to…
BioACCESS Attends WHO Summit on Noncommunicable Diseases
Donovan Guttieres, a research scientist on the BioACCESS initiative, was awarded a grant to attend the Global Meeting to Accelerate Progress on SDG Target 3.4 on Noncommunicable Diseases and Mental Health, with the aim of working towards cutting preventable deaths from NCDs by 75% in the year 2035. Click HERE to read more.
The Singapore-MIT Alliance for Research and Technology announces a new effort in cell therapy manufacturing, CAMP!!
CBI will work on one of three flagship research projects under the Singapore-MIT Alliance for Research and Technology’s new program on Critical Analytics for Manufacturing Personalized-Medicine (SMART CAMP). This effort is supported by the Singapore National Research Foundation and will involve collaboration with leading universities and hospitals in Singapore. SMART News & Events, July 15, 2019